AlloCure Pockets $25M for Acute Kidney Injury Stem Cell Therapy – Genetic Engineering News
AlloCure Pockets $25M for Acute Kidney Injury Stem Cell TherapyGenetic Engineering NewsThe company is developing AC607, an allogeneic mesenchymal stem cell therapy, for acute kidney injury (AKI) and believes that the funding will allow it to complete P…
